DUKORAL, suspension et poudre effervescente pour suspension buvable.Vaccin du choléra (inactivé, buvable)

suspension et poudre effervescent(e) pour suspension buvable · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsuspension et poudre effervescent(e) pour suspension buvable

Routeorale

Ingredient entries5

CountryFrance

Product identity

At a glance

Authorisation holder: VALNEVA SWEDEN (SUEDE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 66974680

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for DUKORAL, suspension et poudre effervescente pour suspension buvable.Vaccin du choléra (inactivé, buvable)
Ingredient	Strength / reference	Source role
SOUS UNITÉ B DE LA TOXINE CHOLÉRIQUE RECOMBINANTE suspension	1 mg3 ml	SAGroup 5
VIBRIO CHOLERAE INABA 48, BIOTYPE CLASSIQUE, INACTIVÉ PAR LA CHALEURsuspension	31,25 * 10^9 bactéries3 ml	SAGroup 1
VIBRIO CHOLERAE OGAWA 50, BIOTYPE CLASSIQUE, INACTIVÉ PAR LA CHALEURsuspension	31,25 * 10^9 bactéries3 ml	SAGroup 3
VIBRIO CHOLERAE INABA 6973, BIOTYPE EL TOR, INACTIVE INACTIVÉ PAR LE FORMALDÉHYDEsuspension	31,25 * 10^9 bactéries3 ml	SAGroup 2
VIBRIO CHOLERAE OGAWA 50, BIOTYPE CLASSIQUE, INACTIVÉ PAR LE FORMALDÉHYDEsuspension	31,25 * 10^9 bactéries3 ml	SAGroup 4

Pack references

Presentations (1)

2 flacon(s) en verre de 3 ml - 2 sachet(s)-dose(s) polyester polyéthylène basse densité (PEBD) aluminium de 5,6 g

CIP13 3400936512580

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 66974680 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →